Cancer · 2006 · 197 citations · 10 references
MedicineOncologyRadiation OncologyChemotherapyHematologic OncologyMedical OncologyAdjuvant ChemotherapyMalignant NeoplasmsRadiation TherapyExtended-field RadiotherapyLymphoma ChemotherapyLymphoma RelapseNon-hodgkin Lymphoma TherapyNon-hodgkin Lymphoma TreatmentOverall MortalityRelapsed Hodgkin LymphomaRelapsed Non-hodgkin Lymphoma
In a randomized, prospective trial from 1974-1978, 73 patients with non-Hodgkin's lymphomas in clinical Stage I or II were treated with extended field radiotherapy alone (RT) or RT plus adjuvant chemotherapy with vincristine, streptonigrin, cyclophosphamide and prednisone (RT + CT). With a median follow-up time of five years, 54% have relapsed in the RT group versus only 10% in the RT + CT group (P less than 0.01). There is no statistical difference in the overall survival yet, but 13/14 deaths in the RT group versus only 3/12 in the RT + CT group were due to progressive disease. Among patients with unfavorable histology, 13/22 in the RT group have died from disease progression against 3/34 in the RT + CT group (P less than 0.01). The results are in agreement with those from two other series published in detail. Based on these results we therefore recommend to use adjuvant CT with RT in all Stage I-II patients with unfavorable histology. Further observation is necessary before a conclusion can be drawn for the lymphoma patients with more favorable histology.
10
A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
E. A. Gehan · Biometrika · 1965 · 3.4K citations
Roy Goulding, G N Volans, Peter Crome et al. · The Lancet · 1976 · 168 citations
Non-Hodgkin's lymphomas.V. Results of radiotherapy
Stephen E. Jones, Zvi Fuks, Henry S. Kaplan et al. · Cancer · 1973 · 136 citations · Full text